...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Differences of Opinion
5
May 24, 2016 10:55AM
4
May 24, 2016 11:48AM
4
May 24, 2016 01:42PM

May 24, 2016 02:55PM
8
May 24, 2016 04:25PM
2
May 24, 2016 06:59PM
1
May 24, 2016 10:59PM
San Fran, I can't help but think that if the share price was higher now, you all would be even more frustrated, given the fact that you can't trade them now anyway. I guess I'm beating my own horse here...with successful results we will definitely have a brighter future ahead. Didn't Don say something like with successful results, the floodgates will open!? Is it possible that the delay in the reorg is because they have a deal already, pending good results? I think Don already painted that picture of Zenith becoming "a base station from which various partnerships and companies can spawn". He has said there could be more spinoffs in the future...hopefully done in the same manner as Zenith was spunoff from RVX. The way I look at it, these Zenith shares are a bonus...and it seems more and more likely, they will be HUUUGGE! I'm sure the big boys are just as anxious for this to work out our way as well. As hard as it is, more patience is required from us peons. jmho PVLee
1
May 24, 2016 11:48PM
Share
New Message
Please login to post a reply